Surgery
Audio Summaries

A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis

The authors aimed to evaluate the efficacy and safety of a 6-month treatment regimen for pulmonary rifampicin-resistant tuberculosis compared to the standard 9-month treatment in South Africa. The study found that the 6-month regimen was noninferior in achieving successful treatment outcomes and had a similar safety profile to the standard regimen. This suggests that the shorter treatment duration may be a viable alternative for managing rifampicin-resistant tuberculosis.

Time to Spare: 1-Minute vs 2-Minute Intercostal Nerve Cryoablation During Minimally Invasive Repair of Pectus Excavatum

This study aimed to determine the optimal duration of intercostal nerve cryoablation (INC) during minimally invasive repair of pectus excavatum (MIRPE) by comparing outcomes between one-minute and two-minute INC applications. The findings suggest that one-minute INC does not negatively impact postoperative pain management while significantly reducing operative time, indicating it may be a viable alternative to the longer duration.

Coexisting Pelviureteric and Vesicoureteric Junction Obstruction in Children: Diagnostic Challenges and Treatment Strategies - A Narrative Review

The authors aim to address the diagnostic and therapeutic challenges associated with coexisting pelviureteric junction obstruction (PUJO) and vesicoureteric junction obstruction (VUJO) in children. Through a narrative review of existing literature, they highlight the significant variability in diagnostic approaches and management strategies, emphasizing the need for individualized treatment that targets the predominant obstruction. The study concludes that further research is necessary to better understand and manage this rare condition.

Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas

The authors aimed to evaluate the long-term outcomes of anti-CD19 CAR T-cell therapy (tisagenlecleucel) in patients with relapsed or refractory B-cell non-Hodgkin lymphomas over a median follow-up of 10.1 years. They found that approximately 32% of patients with large B-cell lymphoma and 47% with follicular lymphoma achieved lymphoma-free survival, with a notable persistence of B-cell aplasia in long-term responders. The study highlights the potential for durable remissions in this patient population, despite some risks of non-relapse-related mortality and secondary cancers.

Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial

The authors aimed to compare the effectiveness of self-directed cognitive behavioral therapy for chronic pain (CBT-CP) with asynchronous feedback to clinician-delivered CBT-CP in patients with chronic musculoskeletal pain. The study found that self-directed CBT-CP significantly reduced pain interference and improved secondary outcomes at 4 months, with benefits sustained at 12 months, suggesting it may be a more accessible alternative to traditional clinician-delivered therapy.

Prevention and Treatment of Peanut Allergy

This paper investigates the effectiveness of early peanut protein introduction and immunotherapy in preventing and treating peanut allergy. The authors find that introducing peanut protein early significantly reduces allergy prevalence, with optimal prevention strategies differing for low and high-risk infants. Additionally, they highlight that immunotherapy is more effective when started in younger children, emphasizing the critical need for early intervention.

Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study

This study aimed to evaluate the safety, tolerability, and preliminary efficacy of AC01, an oral ghrelin receptor agonist, in patients with heart failure with reduced ejection fraction (HFrEF). The results indicated that AC01 was generally safe and well tolerated over 28 days, with no major adverse events reported, suggesting potential for further investigation in larger trials.

Foreign body ingestion in children: impact of a digital app on clinical decision-making

This study investigates the impact of a digital decision-support app on the management of foreign body ingestion (FBI) cases in children, aiming to assess adherence to standardized protocols and identify areas for improvement. The authors found significant deviations from recommended guidelines, particularly among interhospital transfers, suggesting that structured decision-support tools could enhance clinical decision-making and reduce unnecessary interventions. Overall, the findings highlight the need for improved adherence to evidence-based management strategies in pediatric emergency care.

Ethical Implications of the Slow Code: A Systematic Review of Ethics of Slow Codes in U.S. Hospitals

The authors investigate the ethical implications of "slow codes" in U.S. hospitals, where clinicians perform resuscitation efforts without full commitment, often in response to patient or family requests despite the futility of such interventions. Their systematic review of 34 studies reveals a significant divide among physicians regarding the permissibility of slow codes, with most ethics literature deeming them impermissible due to concerns about deception, patient autonomy, and moral distress. The findings underscore the need for improved communication and ethical guidance in navigating end-of-life care decisions.

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial

The authors aimed to evaluate the efficacy and safety of tirofiban, a glycoprotein IIb/IIIa receptor antagonist, in improving functional independence in patients with acute ischaemic stroke following successful endovascular reperfusion. In a multicentre, double-blind, randomized controlled trial involving 1,380 patients, tirofiban was found to significantly increase the likelihood of functional independence at 90 days compared to placebo, although there was no significant difference in the rates of symptomatic intracranial hemorrhage or mortality between the two groups.